LGND Dividend History & Analysis | N/A Yield
LGND has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Dividends Cash Amount per Share Yearly
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 20.9% | 0.31% |
| GILD | 155,333 M | 3.14% | 7.99% |
| ABBV | 410,546 M | 2.86% | 7.80% |
| AMGN | 180,930 M | 2.83% | 4.98% |
| HLN | 44,016 M | 1.83% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 7,645 M | 127% | 60.7% |
| HLN | 44,016 M | 51.0% | 100% |
| AMGN | 180,930 M | 8.90% | 100% |
| ABBV | 410,546 M | 7.06% | 100% |
| GILD | 155,333 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare LGND Dividends with its Peer-Group
2.86% Yield
2.83% Yield
3.14% Yield
1.83% Yield
LGND Dividend History: Last 2 Payments (USD) as of November 2025
| Ex-Dividend Date | Record Date | Payment Date | Period | Dividend per Share | Dividend Growth Rate QoQ | Payout Yield |
|---|---|---|---|---|---|---|
| 2010-07-02 | 2010-06-28 | 0.456 | -95.1% | N/A | ||
| 2007-04-03 | 2007-04-05 | 2007-04-19 | Other | 9.3575 | 0% | N/A |
LGND Dividend FAQ
Ligand Pharmaceuticals (NASDAQ:LGND) is a biopharmaceutical licensing company that discovers, develops, and out-licenses a broad portfolio of therapeutic assets across infectious disease, oncology, rare disease, and specialty indications, generating recurring royalty and milestone revenue streams.
What is the Dividend Yield of LGND?
As of November 2025, LGND`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 199.03.Does LGND pay a dividend?
As of November 2025 LGND does not pay a dividend.How often does LGND pay dividends?
Over the last 12 months, LGND has issued 0 dividend payments. The last dividend payment was made on 2010-07-02.Will LGND pay dividends in 2025?
The latest dividend paid per share was 0.456 USD with an Ex-Dividend Date of 2010-07-02. The next Ex-Dividend date for Ligand Pharmaceuticals (LGND) is currently unknown.What is the next Ex-Dividend Date for LGND?
The next Ex-Dividend date for Ligand Pharmaceuticals (LGND) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of LGND?
LGND's average dividend growth rate over the past 5 years is 0.00% per year.
What is the Yield on Cost of LGND?
LGND's 5-Year Yield on Cost is -%. If you bought LGND's shares at 53.81 USD five years ago, your current annual dividend income (- USD per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of LGND?
LGND Payout Consistency is 0.6%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: Ligand Pharmaceuticals has a poor track record of dividend payments over its lifetime.
Does LGND have a good Dividend Yield?
LGND`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of LGND?
The Dividend Payout Ratio of LGND is unknown.What is the Dividend Rating of LGND?
LGND`s Overall Dividend Rating is 0.14%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-11-11 10:37